Enzo Biochem Stock Today
| ENZ Stock | USD 1.09 0.04 3.54% |
Performance0 of 100
| Odds Of DistressLess than 34
|
Enzo Biochem is trading at 1.09 as of the 24th of April 2024; that is -3.54 percent decrease since the beginning of the trading day. The stock's open price was 1.13. Enzo Biochem has about a 34 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Enzo Biochem are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 12th of June 1980 | Category Healthcare | Classification Health Care |
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company was founded in 1976 and is headquartered in Farmingdale, New York. The company has 51.23 M outstanding shares of which 720.55 K shares are currently shorted by investors with about 8.27 days to cover. More on Enzo Biochem
Moving together with Enzo Stock
| 0.77 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Enzo Stock
| 0.78 | AA | Alcoa Corp Financial Report 17th of July 2024 | PairCorr |
| 0.74 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
| 0.72 | MMM | 3M Company Earnings Call This Week | PairCorr |
| 0.61 | CAT | Caterpillar Earnings Call Tomorrow | PairCorr |
| 0.59 | CVX | Chevron Corp Earnings Call This Week | PairCorr |
| 0.59 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.46 | AXP | American Express Financial Report 19th of July 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Enzo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Enzo Biochem's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Enzo Biochem or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Hamid Erfanian | ||||
| Thematic Idea | Healthcare (View all Themes) | ||||
| Old Names | [ENEL GREEN POWER , ENEL GREEN POWER - Dusseldorf Stock Exchang, ENEL GREEN POWER (ENZ.SG), Enzumo Limited] | ||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, Healthcare, Health Care, Health Care Providers & Services, Diagnostics & Research, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Enzo Biochem report their recommendations after researching Enzo Biochem's financial statements, talking to executives and customers, or listening in on Enzo Biochem's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Enzo Biochem. The Enzo consensus assessment is calculated by taking the average forecast from all of the analysts covering Enzo Biochem. | |||||
Enzo Biochem's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Enzo Biochem's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Enzo Biochem's financial leverage. It provides some insight into what part of Enzo Biochem's total assets is financed by creditors.
| |||||
Enzo Biochem (ENZ) is traded on New York Stock Exchange in USA. It is located in 81 Executive Blvd., Farmingdale, NY, United States, 11735 and employs 179 people. Enzo Biochem is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 55.84 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Enzo Biochem's market, we take the total number of its shares issued and multiply it by Enzo Biochem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Enzo Biochem runs under Health Care Providers & Services sector within Health Care industry. The entity has 51.23 M outstanding shares of which 720.55 K shares are currently shorted by investors with about 8.27 days to cover.
Enzo Biochem has about 82.37 M in cash with (36.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Check Enzo Biochem Probability Of Bankruptcy
Ownership AllocationEnzo Biochem retains a total of 51.23 Million outstanding shares. Enzo Biochem retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Enzo Ownership Details
Enzo Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Enzo Biochem jumping above the current price in 90 days from now is close to 99%. The Enzo Biochem probability density function shows the probability of Enzo Biochem stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Enzo Biochem has a beta of -0.082 suggesting as returns on the benchmark increase, returns on holding Enzo Biochem are expected to decrease at a much lower rate. During a bear market, however, Enzo Biochem is likely to outperform the market. Additionally, enzo Biochem has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Enzo Biochem to move above the current price in 90 days from now is close to 99 (This Enzo Biochem probability density function shows the probability of Enzo Stock to fall within a particular range of prices over 90 days) .
Enzo Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Enzo Biochem that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Enzo Biochem's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Enzo Biochem's value.| Instituion | Recorded On | Shares | |
| State Street Corporation | 2023-12-31 | 167 K | |
| Northern Trust Corp | 2023-12-31 | 113.3 K | |
| Fny Investment Advisers, Llc | 2023-12-31 | 75.9 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 75.8 K | |
| Assenagon Asset Management Sa | 2023-12-31 | 72.4 K | |
| Wittenberg Investment Management Inc | 2023-12-31 | 68 K | |
| Lazard Asset Management Llc | 2023-12-31 | 50.5 K | |
| T. Rowe Price Associates, Inc. | 2023-12-31 | 44.8 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 26.2 K | |
| Harbert Fund Advisors Inc | 2023-12-31 | 5.2 M | |
| Renaissance Technologies Corp | 2023-12-31 | 2.5 M |
Enzo Biochem Historical Income Statement
Enzo Biochem Income Statement is one of the three primary financial statements used for reporting Enzo's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Enzo Biochem revenue and expense. Enzo Biochem Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Enzo Biochem's Extraordinary Items is fairly stable compared to the past year. Selling And Marketing Expenses is likely to rise to about 469.3 K in 2024, whereas Depreciation And Amortization is likely to drop slightly above 2.7 M in 2024. View More FundamentalsEnzo Stock Against Markets
Picking the right benchmark for Enzo Biochem stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Enzo Biochem stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Enzo Biochem is critical whether you are bullish or bearish towards Enzo Biochem at a given time. Please also check how Enzo Biochem's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Enzo Biochem without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Enzo Biochem Corporate Directors
Enzo Biochem corporate directors refer to members of an Enzo Biochem board of directors. The board of directors generally takes responsibility for the Enzo Biochem's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Enzo Biochem's board members must vote for the resolution. The Enzo Biochem board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Mary Tagliaferri | Lead Independent Director | Profile | |
| Dov Perlysky | Lead Independent Director | Profile | |
| Ian Walters | Independent Director | Profile | |
| Gregory Bortz | Lead Independent Director | Profile |
How to buy Enzo Stock?
Before investing in Enzo Biochem, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Enzo Biochem. To buy Enzo Biochem stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Enzo Biochem. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Enzo Biochem stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Enzo Biochem stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Enzo Biochem stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Enzo Biochem, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.
Already Invested in Enzo Biochem?
The danger of trading Enzo Biochem is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Enzo Biochem is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Enzo Biochem. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Enzo Biochem is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Enzo Biochem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enzo Biochem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enzo Biochem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enzo Biochem Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Enzo Stock analysis
When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Enzo Biochem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enzo Biochem. If investors know Enzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enzo Biochem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.657 | Quarterly Revenue Growth 0.138 | Return On Assets (0.17) | Return On Equity (0.45) |
The market value of Enzo Biochem is measured differently than its book value, which is the value of Enzo that is recorded on the company's balance sheet. Investors also form their own opinion of Enzo Biochem's value that differs from its market value or its book value, called intrinsic value, which is Enzo Biochem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enzo Biochem's market value can be influenced by many factors that don't directly affect Enzo Biochem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enzo Biochem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enzo Biochem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzo Biochem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.